Bivalency of natalizumab promotes inhibition of dynamic VLA-4 adhesion beyond affinity gain.

Valignat M-P, Biarnes-Pelicot M, Touchard D, Rico-Lamy A, Chames P, Theodoly O, Robert P

Integr Biol (Camb). 2026 Jan 16; 18. PMID: 42537011. Abstract